Literature DB >> 2155921

Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet.

R D Feldman1.   

Abstract

Hypertensive patients have reduced lymphocyte beta-adrenergic responsiveness which is corrected by a low sodium (Na) diet. To determine if this represents a more generalized abnormality in beta adrenoceptor response, we studied beta adrenergic-mediated vasodilation in hand veins of borderline hypertensive subjects and controls. Subjects received a 5-d diet containing high Na/low potassium (K), high Na/high K, or low Na/high K. Venous distension, as evaluated by a linear variable differential transformer, was measured in relation to infusion of phenylephrine followed by isoproterenol and nitroglycerin. On both the high Na/high K and high Na/low K diets, hypertensive subjects had significantly decreased isoproterenol-mediated vasodilation (47% decrease, P less than 0.01 and 36% decrease, P less than 0.01, respectively). On the low Na/high K diet, isoproterenol-mediated vasodilation in hypertensive subjects increased 41% (P less than 0.01) to a level not different from controls. Nitroglycerin-mediated vasodilation was not different in normotensive and hypertensive subjects, nor was it altered with Na intake. Phenylephrine-mediated vasoconstriction did not differ between normotensive and hypertensive groups. Venous beta-adrenergic response correlated with lymphocyte beta adrenoceptor density in normotensive (r = 0.53, P less than 0.005) but not hypertensive subjects. This study demonstrates that beta-adrenergic responsiveness is selectively reduced in peripheral veins of borderline hypertensive subjects, and this is corrected by a low Na diet. In view of our previous findings of reduced lymphocyte beta-adrenergic responsiveness in borderline hypertension, these studies suggest a generalized defect of beta adrenoceptor responsiveness in human hypertension. Further, dietary Na may play an important role in regulating this abnormality.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155921      PMCID: PMC296478          DOI: 10.1172/JCI114487

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm: differences between normotensive and hypertensive subjects.

Authors:  K Jie; P van Brummelen; P Vermey; P B Timmermans; P A van Zwieten
Journal:  J Hypertens Suppl       Date:  1985-12

2.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Decreased venous distensibility in borderline hypertension.

Authors:  A Takeshita; A L Mark
Journal:  Hypertension       Date:  1979 May-Jun       Impact factor: 10.190

5.  Contribution of cardiovascular reflexes to differences in beta-adrenoceptor-mediated responses in essential hypertension.

Authors:  G Jennings; A Bobik; M Esler; P Korner
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

Review 6.  The pathogenesis of hypertension: the Baker concerto.

Authors:  P I Korner
Journal:  Clin Exp Hypertens A       Date:  1984

7.  Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man.

Authors:  W H Aellig
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.

Authors:  A De Lean; A A Hancock; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

9.  Effects of moderate salt restriction on intralymphocytic sodium and pressor response to stress in borderline hypertension.

Authors:  E Ambrosioni; F V Costa; C Borghi; L Montebugnoli; M F Giordani; B Magnani
Journal:  Hypertension       Date:  1982 Nov-Dec       Impact factor: 10.190

10.  Leukocyte beta-receptor alterations in hypertensive subjects.

Authors:  R D Feldman; L E Limbird; J Nadeau; D Robertson; A J Wood
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

View more
  18 in total

1.  Effects of different congestion pressures on the diameter of the dorsal hand vein and on its apparent sensitivity to noradrenaline.

Authors:  A H Abdelmawla; R W Langley; E Szabadi; C M Bradshaw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

Review 2.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

3.  Interactions between beta-2 adrenoceptor gene variation, cardiovascular control and dietary sodium in healthy young adults.

Authors:  John H Eisenach; Darrell R Schroeder; Emily S Pavey; Alan R Penheiter; Jean N Knutson; Stephen T Turner; Michael J Joyner
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

Review 4.  Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein-coupled receptor structure and function.

Authors:  Aditya J Desai; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

5.  Effects of gender, age and hypertension on beta-adrenergic receptor function in rat urinary bladder.

Authors:  Elfaridah P Frazier; Tim Schneider; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-31       Impact factor: 3.000

6.  Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients.

Authors:  Raffaele Izzo; Ersilia Cipolletta; Michele Ciccarelli; Alfonso Campanile; Gaetano Santulli; Gianluigi Palumbo; Antonio Vasta; Salvatore Formisano; Bruno Trimarco; Guido Iaccarino
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

7.  Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension.

Authors:  C M Stein; R Nelson; R Deegan; H He; M Wood; A J Wood
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 8.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

9.  Conducting the G-protein Coupled Receptor (GPCR) Signaling Symphony in Cardiovascular Diseases: New Therapeutic Approaches.

Authors:  Stephen L Belmonte; Burns C Blaxall
Journal:  Drug Discov Today Dis Models       Date:  2012-06-27

10.  Insulin-mediated sensitization of adenylyl cyclase activation.

Authors:  R D Feldman
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.